Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/7/e006348corr1.full
_version_ 1797768205675003904
collection DOAJ
first_indexed 2024-03-12T20:50:04Z
format Article
id doaj.art-5eafb48829be471bb82a79236a79bc17
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-12T20:50:04Z
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-5eafb48829be471bb82a79236a79bc172023-08-01T04:30:06ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-07-0111710.1136/jitc-2022-006348corr1Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumorshttps://jitc.bmj.com/content/11/7/e006348corr1.full
spellingShingle Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Journal for ImmunoTherapy of Cancer
title Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
title_full Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
title_fullStr Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
title_full_unstemmed Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
title_short Correction: Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
title_sort correction anti hvem mab therapy improves antitumoral immunity both in vitro and in vivo in a novel transgenic mouse model expressing human hvem and btla molecules challenged with hvem expressing tumors
url https://jitc.bmj.com/content/11/7/e006348corr1.full

Similar Items